GAMMA SOLUTIONS has expanded its consulting services to Atlanta’s pharmaceutical sector, focusing on IT operations and AI implementation to help pharma companies advance digital transformation and drive growth.
-- GAMMA SOLUTIONS has expanded its consulting services for pharmaceutical organizations in Atlanta, bringing its outcome-oriented approach to IT operations, digital transformation, systems optimization, and AI implementation. Rather than limiting its role to technology recommendations, the consultancy works across strategy, systems, operations, and organizational alignment to help clients move complex technology initiatives from planning into execution.
More information is available at https://www.gamma-solutions.llc/
The expansion comes as artificial intelligence adoption is advancing across the pharmaceutical and broader life sciences sectors; however, implementation and measurable results do not always keep pace. Deloitte’s June 2026 midyear Life Sciences Outlook found that 71% of surveyed executives said AI deployment had advanced at least somewhat, while only 13% reported measurable improvement at scale.
For pharmaceutical organizations, moving an AI initiative into production can affect more than the technology itself. Existing systems, operational processes, data requirements, and leadership structures may all need to be considered as new capabilities are introduced.
That broader view is reflected in GAMMA SOLUTIONS’ consulting model, which extends beyond individual technology projects to include leadership and program management, technical due diligence, business problem-solving and crisis management, and organizational alignment. The consultancy also provides fractional CIO, CTO, and COO services for organizations requiring additional technology leadership.
AI and machine learning are also addressed through GAMMA SOLUTIONS’ digital integration services. The consultancy helps organizations determine when AI and ML implementation is appropriate and partners with clients through execution, rather than treating AI as a standalone technology decision.
Additional information about the company's services can be found at https://www.gamma-solutions.llc/services
More than half a dozen case studies are available on the GAMMA SOLUTIONS website, covering work with pharmaceutical, biotechnology, medical technology, healthcare, and other organizations. The examples illustrate the consultancy’s work across IT operations, digital transformation, technology strategy, and organizational requirements.
The Atlanta expansion adds another market to GAMMA SOLUTIONS’ consulting footprint as the company continues to support organizations through periods of technology-driven growth and transformation.
About GAMMA Solutions
GAMMA SOLUTIONS is owned and operated by founder and CEO Gilles-André Morin, known to many simply as G.-A. His IT career has taken him across multiple industries, including pharmaceutical, biotechnology, healthcare, and financial technology, giving him experience with both strategic technology planning and hands-on IT operations.
To read more about GAMMA SOLUTIONS' work, visit https://www.gamma-solutions.llc/case-studies
Contact Info:
Name: Gilles-Andre' Morin
Email: Send Email
Organization: GAMMA SOLUTIONS, LLC
Address: 45 Nonantum St., Newton, MA 02458, United States
Website: https://www.gamma-solutions.llc
Source: PressCable
Release ID: 89201380
In case of encountering any inaccuracies, problems, or queries arising from the content shared in this press release that necessitate action, or if you require assistance with a press release takedown, we urge you to notify us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be readily available to promptly address your concerns within 8 hours, resolving any identified issues diligently or guiding you through the necessary steps for removal. The provision of accurate and dependable information is our primary focus.
